Literature DB >> 16158822

Reactivation of latent Epstein Barr virus infection induces remission of splenic lymphoma with villous lymphocytes.

Markus Hansson1, Annika Linde, Inge Olsson.   

Abstract

Splenic lymphoma with villous lymphocytes (SLVL) is a rare, slowly progressing, lymphoproliferative disease of B-cell origin. Treatment aimed at cure or remission is limited, and spontaneous remission has not been described. We report on a patient who after 4 years with untreated SLVL developed symptoms of mononucleosis and was found to have reactivation of latent Epstein-Barr virus (EBV) infection. During recovery from the EBV infection, complete remission from SLVL developed and lasted for 3 years, suggesting that the EBV infection induced an immune response that caused the SLVL remission.

Entities:  

Mesh：

Year:  2005        PMID： 16158822     DOI： 10.1532/ijh97.e0434

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  11 in total

1.  Spontaneous phenotypic and molecular blood remission in a case of chronic lymphocytic leukaemia.

Authors:  M Bernard; B Drenou; C Pangault; C Dauriac; R Fauchet; P Y LePrisé; T Lamy
Journal:  Br J Haematol       Date:  1999-10       Impact factor: 6.998

2.  Spontaneous clinical regression in chronic lymphocytic leukaemia.

Authors:  Ranjit Thomas; Isabel Ribeiro; Patricia Shepherd; Peter Johnson; Margaret Cook; Anil Lakhani; Richard Kaczmarski; Patrick Carrington; Daniel Catovsky
Journal:  Br J Haematol       Date:  2002-02       Impact factor: 6.998

3.  Rapid turnover of T cells in acute infectious mononucleosis.

Authors:  Derek C Macallan; Diana L Wallace; Andrew J Irvine; Becca Asquith; Andrew Worth; Hala Ghattas; Yan Zhang; George E Griffin; David F Tough; Peter C Beverley
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

Review 4.  Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.

Authors:  D Oscier; C Fegan; P Hillmen; T Illidge; S Johnson; P Maguire; E Matutes; D Milligan
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

5.  Transient regression in lymphocyte count in B-cell chronic lymphocytic leukemia after viral infection.

Authors:  K Shirono; M Ikebe; T Inada; H Tsuda
Journal:  Acta Haematol       Date:  1995       Impact factor: 2.195

6.  Peripheral blood remission of hairy cell leukemia after transfusion hepatitis.

Authors:  M J Keefer; M J Weber; S S Bottomley; D L Solanki; T A Hosty
Journal:  Am J Hematol       Date:  1987-07       Impact factor: 10.047

7.  Remission of hairy cell leukemia without treatment.

Authors:  N Abramson; S Castro
Journal:  Haematologia (Budap)       Date:  1997

8.  Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.

Authors:  A Linde; B Kallin; J Dillner; J Andersson; L Jägdahl; A Lindvall; B Wahren
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

9.  Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.

Authors:  B D Cheson; J M Bennett; K R Rai; M R Grever; N E Kay; C A Schiffer; M M Oken; M J Keating; D H Boldt; S J Kempin
Journal:  Am J Hematol       Date:  1988-11       Impact factor: 10.047

Review 10.  [Spontaneous remission in chronic lymphatic leukemia].

Authors:  S Frick; P Frick
Journal:  Schweiz Med Wochenschr       Date:  1993-02-27
View more
  1 in total

Review 1.  Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.

Authors:  Xavier Troussard; Edouard Cornet
Journal:  Curr Treat Options Oncol       Date:  2007-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.